Erratum to "Phase I, randomized, observer-blind, placebo-controlled studies to evaluate the safety, reactogenicity and immunogenicity of an investigational non-typeable Haemophilus influenzae (NTHi) protein vaccine in adults" [Vaccine 34 (2016) 3156-3163]
Vaccine. 2017 Oct 9;35(42):5729-5730.
doi: 10.1016/j.vaccine.2017.08.076.
Epub 2017 Sep 4.
1 Center for Vaccinology, Ghent University and Ghent University Hospital, BC001, De Pintelaan 185, B-9000 Ghent, Belgium. Electronic address: [email protected].
2 Centre for the Evaluation of Vaccination, University of Antwerp, Campus Drie Eiken, Universiteitsplein 1, 2610 Antwerp, Belgium. Electronic address: [email protected].
3 SGS Life Sciences Services, Lange Beeldekensstraat 267, 2060 Antwerp, Belgium. Electronic address: [email protected].
4 University of Adelaide, Mail Delivery Point 22, Royal Adelaide Hospital, North Terrace, 5000 Adelaide, Australia. Electronic address: [email protected].
5 GSK Vaccines, Rue de l'Institut 89, 1330 Rixensart, Belgium. Electronic address: [email protected].
6 GSK Vaccines, Rue de l'Institut 89, 1330 Rixensart, Belgium. Electronic address: [email protected].
7 GSK Vaccines, Rue de l'Institut 89, 1330 Rixensart, Belgium. Electronic address: [email protected].
8 GSK Vaccines, Rue de l'Institut 89, 1330 Rixensart, Belgium. Electronic address: [email protected].